EBAMed SA, an early-stage medical device company pioneering new approaches to proton therapy today announced the enrollment of the first patient in a prospective imaging study using a device that automatically interprets cardiac ultrasound images to uniquely track the motion of the heart. The first patient was enrolled at the Policlinico San Matteo, Pavia (Italy). This […]
continue readingSwiss-based medtech startup EBAMed appoints Marina Izzo as CEO
EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022. Former CEO and co-founder, Adriano Garonna has transitioned to Chief […]
continue reading